Positive phase 3 data for Sanofi’s Dupixent
Research showed significant improvements in signs and symptoms of prurigo nodularis
Read More
Tag: Phase 3
AstraZeneca’s Eplontersen meets endpoints in critical phase 3 trial
Eplontersen significantly improved patient-reported quality of life following successful research
Read More
AstraZeneca kidney inflammation treatment trial reaches dosing stage
Initial group of patients have received Saphnelo in a phase 3 trial evaluating lupus nephritis
Read More
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
